Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of CD3 antibodies in transplantation and autoimmune diseases.

× No keyword cloud information.

6 in total

Review 1. Autologous regulatory T cells for the treatment of type 1 diabetes.

Authors: James A Thompson; Daniel Perry; Todd M Brusko
Journal: Curr Diab Rep Date: 2012-10 Impact factor: 4.810

Review 2. Connecting type 1 and type 2 diabetes through innate immunity.

Authors: Justin I Odegaard; Ajay Chawla
Journal: Cold Spring Harb Perspect Med Date: 2012-03 Impact factor: 6.915

Review 3. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.

Authors: M I Wilde; K L Goa
Journal: Drugs Date: 1996-05 Impact factor: 9.546

4. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

Authors: Kevan C Herold; Joshua B Burton; Fleur Francois; Ena Poumian-Ruiz; Mariela Glandt; Jeffrey A Bluestone
Journal: J Clin Invest Date: 2003-02 Impact factor: 14.808

Review 5. Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Authors: Brett Phillips; Massimo Trucco; Nick Giannoukakis
Journal: Clin Dev Immunol Date: 2011-07-18

6. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.

Authors: Kevan C Herold; Stephen E Gitelman; Umesh Masharani; William Hagopian; Brygida Bisikirska; David Donaldson; Kristina Rother; Beverly Diamond; David M Harlan; Jeffrey A Bluestone
Journal: Diabetes Date: 2005-06 Impact factor: 9.461

6 in total